Lugnier, C., Al-Kuraishy, H. M., & Rousseau, E. (2021). PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol.
Style de citation ChicagoLugnier, Claire, Hayder M. Al-Kuraishy, et Eric Rousseau. "PDE4 Inhibition As a Therapeutic Strategy for Improvement of Pulmonary Dysfunctions in Covid-19 and Cigarette Smoking." Biochem Pharmacol 2021.
Style de citation MLALugnier, Claire, Hayder M. Al-Kuraishy, et Eric Rousseau. "PDE4 Inhibition As a Therapeutic Strategy for Improvement of Pulmonary Dysfunctions in Covid-19 and Cigarette Smoking." Biochem Pharmacol 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.